PAP
FHTX icon

Persistent Asset Partners’s Foghorn Therapeutics FHTX Stock Holding History

Persistent Asset Partners’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Buy
46,872
+228
+0.5% +$1.01K 0.07% 197
2026
Q1 		$223K Sell
46,644
-464
-1% -$2.55K 0.08% 185
2025
Q4 		$254K Buy
47,108
+35,667
+312% +$162K 0.11% 198
2025
Q3 		$55.9K Buy
+11,441
New +$60.7K 0.04% 176

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Persistent Asset Partners's FHTX Position: Q2 2026 in Review

Persistent Asset Partners increased its Foghorn Therapeutics (FHTX) stake by 0.49% in Q2 2026, buying an estimated $1.01K and bringing the position to 46,872 shares worth $229K. The position accounts for 0.07% of the portfolio, ranked #197.

Persistent Asset Partners first reported a position in FHTX in Q3 2025 and has held it in 4 quarters since. The position peaked at $254K in Q4 2025. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Persistent Asset Partners held 46,872 shares of Foghorn Therapeutics worth $229K as of Q2 2026.
  • Persistent Asset Partners bought 228 Foghorn Therapeutics shares in Q2 2026, an estimated $1.01K.
  • Foghorn Therapeutics made up 0.07% of Persistent Asset Partners's portfolio in Q2 2026, its #197 holding.
  • Persistent Asset Partners first reported a position in Foghorn Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Persistent Asset Partners's Foghorn Therapeutics position peaked at $254K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.